Status: Recruiting
Efficacy and Safety of Lenalidomide Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma
This study aims to compare the efficacy and safety of lenalidomide plus CHOP (L-CHOP) versus CHOP alone in patients with previously untreated peripheral T-cell lymphoma (PTCL)
Participants needed: 289
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Second Affiliated Hospital, School of Medicine, Zhejiang UniversityUpdated: Nov 7, 2022Locations: 1
Eligibility criteria
Patients with histologically proven untreated peripheral T-cell lymphoma (includ... [+10]
Patients with the following PTCL subtypes are excluded; extranodal natural kille... [+15]